GLP-1 Receptor Agonist Market Key Players Novo Nordisk A/S (Ozempic, Wegovy, Rybelsus, Victoza, Saxenda) Eli Lilly and Company (Mounjaro, Zepbound, Trulicity) AstraZeneca PLC (Byetta, Bydureon BCise) Sanofi SA GlaxoSmithKline plc Pfizer Inc
M.et al (2003a)
This action is especially important for people with Type 2 diabetes, whose pancreas does not produce enough insulin
Acetyl L-Carnitine (ALCAR) is the acetylated form of the naturally occurring amino-acid derivative L-Carnitine
The agency periodically updates prescribing information and issues safety communications when new evidence warrants changes to clinical practice recommendations
But before diving into trial results for past and present obesity medications, it is interesting to consider: what are the remaining questions in GLP-1 and GIP biology in 2023